AI & Diagnostics Software in Maryland

MagBio Genomics Inc. is a biotechnology company specializing in magnetic bead-based products for nucleic acid isolation and purification. Based in Gaithersburg, Maryland, the company develops comprehensive solutions for next-generation sequencing (NGS) workflows, genomic research, and clinical diagnostics. Their product portfolio includes DNA and RNA extraction kits, viral nucleic acid purification reagents, sample collection and stabilization products, post-PCR cleanup reagents, and NGS library preparation kits. MagBio's magnetic bead-based chemistry is compatible with both manual and automated laboratory platforms, supporting applications in cancer genomics, non-invasive prenatal testing (NIPT), viral diagnostics, and long-read sequencing. The company also provides OEM and custom solution development, along with distribution partnerships for life sciences research and clinical laboratories.

EpiWatch is an FDA-cleared, prescription-based mobile health platform that delivers real-time tonic-clonic seizure detection and alerting via Apple Watch and iPhone. The AI-powered application runs passively on wearable devices to monitor seizure activity and provides immediate alerts to caregivers when critical events occur, enabling rapid intervention and reducing the risk of Sudden Unexpected Nocturnal Death in Epilepsy (SUDEP). Designed for both pediatric and adult patients with epilepsy, EpiWatch integrates with family sharing and caregiver contact systems, requiring cellular or Wi-Fi connectivity for continuous monitoring. Available by prescription only in the United States at a monthly subscription fee, the platform empowers patients with independence while providing caregivers actionable intelligence during life-threatening events.

Radiopharmaceutical Imaging and Dosimetry (Rapid), LLC is a Baltimore-based biotechnology research company founded by Johns Hopkins University experts (Drs. George Sgouros, Eric Frey, and Michael Ghaly). Rapid specializes in quantitative imaging, dosimetry analysis, and precision medicine support for radiopharmaceutical therapies, particularly in oncology. The company provides comprehensive consulting and centralized solutions covering the full workflow from image acquisition protocol development through regulatory support and dosimetry reporting. Services include agent-specific imaging protocol design, centralized vendor-independent SPECT/CT quantitative reconstruction with advanced scatter and crosstalk compensation, and expert dosimetry analysis to optimize patient outcomes and reduce normal organ toxicity. Rapid also develops software solutions, including 3D-RD-S, a SaaS platform for radiopharmaceutical dosimetry calculations and radiobiological response modeling. The company combines 45+ years of NIH-funded research and development experience to standardize and simplify dosimetry for routine precision dosing of radiopharmaceutical therapies.